| 000 | 01511 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514222629.0 | ||
| 264 | 0 | _c20050614 | |
| 008 | 200506s 0 0 eng d | ||
| 022 | _a0946-1965 | ||
| 024 | 7 |
_a10.5414/cpp43154 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKaeser, B | |
| 245 | 0 | 0 |
_aAssessment of the bioequivalence of two nelfinavir tablet formulations under fed and fasted conditions in healthy subjects. _h[electronic resource] |
| 260 |
_bInternational journal of clinical pharmacology and therapeutics _cMar 2005 |
||
| 300 |
_a154-62 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aFasting _xmetabolism |
| 650 | 0 | 4 | _aFood |
| 650 | 0 | 4 |
_aHIV Protease Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLinear Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNelfinavir _xadministration & dosage |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 700 | 1 | _aCharoin, J E | |
| 700 | 1 | _aGerber, M | |
| 700 | 1 | _aOxley, P | |
| 700 | 1 | _aBirnboeck, H | |
| 700 | 1 | _aSaiedabadi, N | |
| 700 | 1 | _aBanken, L | |
| 773 | 0 |
_tInternational journal of clinical pharmacology and therapeutics _gvol. 43 _gno. 3 _gp. 154-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5414/cpp43154 _zAvailable from publisher's website |
| 999 |
_c15463229 _d15463229 |
||